Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

FDA commissioner pledges to investigate mifepristone

by
June 3, 2025
in Health Care
0
FDA commissioner pledges to investigate mifepristone

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.).  

“As with all drugs, FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of early pregnancy,” Makary wrote to Hawley.  

“As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists at the Agency who review this data,” he added in the letter.

Makary did not provide any further details about the forthcoming review since the abortion drug is a part of ongoing litigation.  

Hawley has previously pressured the agency to review the drug. Last month, the senator sent a letter to Makary urging him to review new data released on mifepristone and to “restore critical safeguards” on the drug’s use.  

In the same letter, he also criticized Makary for stating that he has “no plans to take action” on mifepristone during a journalism convention.

The data Hawley referred comes from a study published in April by The Ethics and Public Policy Center, a conservative think tank with a mission to “pushback against the extreme progressive agenda.” 

The group claims that nearly 11 percent of women who undergo an abortion using mifepristone experience a “serious adverse event,” which is a far higher rate than the 0.5 percent rate determined in other clinical studies.  

But the study is deeply flawed and filled with what researchers have called “junk science.” The study does not clearly state the database where it obtained the nearly 865,000 insurance claims on prescribed mifepristone abortions.  

The research breaks down the “serious adverse events” by category but places the majority of those events into a vague category called “other abortion-specific complications.”  

The FDA first approved the use of mifepristone for an abortion as part of two-drug regimen with misoprostol in 2000.  

Medication abortions do not need to take place in a clinic setting with patients able to pick up the pills at a clinic to then take home or receive them in the mail.  

More than 100 scientific studies have been conducted examining the safety and efficacy of mifepristone and misoprostol, with all of them finding that the drugs are a safe way to end a pregnancy.  

Most abortions in the U.S. are medication abortions. In 2023, 63 percent of all abortions provided by clinicians in the country were medication abortions, according to data from the reproductive health and rights group the Guttmacher Institute.  

Three Republican-led states — Idaho, Missouri and Kansas — filed a lawsuit against the FDA challenging its previous approval of mifepristone. The Supreme Court dismissed the case last year, arguing that private parties did not have a legal basis to challenge access to the drug.  

But a Texas federal judge ruled in January that the three states could resume their lawsuit aimed at restricting access to mifepristone. 

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has also pushed for a review of the drug. President Trump, after winning the election last November, said it was “unlikely” that he would revoke access to the drug.

Previous Post

Axelrod: Ernst response to Medicaid remarks ‘insensitive,’ ‘politically stupid’

Next Post

Republicans on defense over Medicaid

Next Post
Republicans on defense over Medicaid

Republicans on defense over Medicaid

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    Trump demands drugmakers ‘justify’ COVID treatment success

    Trump demands drugmakers ‘justify’ COVID treatment success

    September 1, 2025
    Former CDC directors sound alarm over Kennedy’s agency shake-up

    Former CDC directors sound alarm over Kennedy’s agency shake-up

    September 1, 2025
    Candida auris: Study reveals who is most vulnerable to deadly fungus infection

    Candida auris: Study reveals who is most vulnerable to deadly fungus infection

    September 1, 2025

    Trending

    New frontiers in cancer care

    New frontiers in cancer care

    December 5, 2024
    Fewer than half of U.S. jails provide medications for opioid use disorder

    Fewer than half of U.S. jails provide medications for opioid use disorder

    September 24, 2024
    Alarm grows over possible RFK Jr. role at HHS if Trump wins

    Alarm grows over possible RFK Jr. role at HHS if Trump wins

    September 6, 2024
    BMI is B-A-D, a new study suggests. Here’s a better way to measure weight

    BMI is B-A-D, a new study suggests. Here’s a better way to measure weight

    June 30, 2025

    Recent News

    Trump demands drugmakers ‘justify’ COVID treatment success

    Trump demands drugmakers ‘justify’ COVID treatment success

    September 1, 2025
    Former CDC directors sound alarm over Kennedy’s agency shake-up

    Former CDC directors sound alarm over Kennedy’s agency shake-up

    September 1, 2025

    Popular News

    • Trump demands drugmakers ‘justify’ COVID treatment success
    • Former CDC directors sound alarm over Kennedy’s agency shake-up

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.